Research Projects & Grants For Profit Organization Latino Semaglutide Study (LSS), Role: Investigator, Novo Nordisk Pharmaceuticals Inc., (07/2022 - 10/2024) Status: Completed Internal The Weight Loss Journey of Center for Health Promotion Patients who have taken the Weight-Loss Medication Saxenda, a GLP-1 (Glucagon Like Peptide 1) Analogue, Role: PI, LLU Dept
At 2 weeks, an increase in the expression of the apoptosis-associated markers BCL-2-associated X protein (BAX) and caspase 3, as well as the microglial cell markers OX42 and ectodermal dysplasia 1 (ED1), was seen in the trauma zone
For many people, especially those dealing with stubborn weight gain, this signal can feel quieter than it should
We offer trusted support, clear prices, and reliable compounded medication options.